News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
In this recorded event, which took place on the six-year anniversary of the first approved CAR-T Levine, discusses emerging technology trends that might improve CAR-T therapies.
“This technology has the potential to become a cornerstone in the field of nanomedicine, beyond RNA-based therapies,” Mitchell said in the Penn Today article.
In August 2023, The GRASP (Penn Engineering’s General Robotics, Automation, Sensing, & Perception) Lab’s Treehouse officially opened at Pennovation Works.
During the 2022 fiscal year, there were 98 press mentions for PCI programs, startups and partners. Some of the most popular and widely circulated stories are included here.
The the Penn Center for Innovation, along with Penn Engineering and Penn Medicine, presented speaker sessions with experts in the field.
Penn spinout Apellis Pharmaceuticals, Inc. received U.S. Food and Drug Administration (FDA) approval for their drug SYFOVRE™ (pegcetacoplan injection).
The Philadelphia Department of Commerce recently issued a $250,000 grant to the Community College of Philadelphia (CCP) for their cell and gene therapy industry lab technician certificate program.
The Fire Awards are PHL Inno’s premiere awards program, showcasing the businesses, institutions and individuals driving the Philadelphia region’s innovation scene forward.
Once completed, the new facility, equipped with next-generation hybrid classrooms and laboratories, will support research in a variety of engineering sectors.
Onocor, a company formed through the UPstart program, has entered into an Amended and Restated License Agreement (ARLA) with Penn to expand its existing license to the ONO medical device.